News
The IQOS Investment Thesis Is Still Robust Philip Morris International (NYSE:PM) has reported a mixed report card for FQ1’23, in our opinion. It reported...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Investing in high-growth opportunities across industries, employing a value investing approach that prioritizes robust business models and strategic...
News
This article was written by Follow I’m a full time value investor and writer who enjoys using classical value ratios to pick my portfolio....
News
This article was written by Follow Buffett-style rational value picks | Top 95th percentile of financial bloggers according to TipRanks.Six years of long-horizon investment...
News
uniQure N.V. (NASDAQ:QURE), a trailblazing gene therapy firm, stands out as a compelling investment opportunity poised to redefine the treatment landscape for various challenging...
News
If the Federal Reserve is serious about “fighting inflation” enough to bring it down to their 2% target, then we believe inflation is still...
News
I have covered Kratos (NASDAQ:KTOS) in the past. The last time I covered the stock it was to discuss the cooperation with Boom to...
News
Investment Summary Imperial Oil Limited (NYSE:IMO) is a Canadian company that specializes in the exploration, production, refining, and marketing of petroleum products. The company’s...
News
The Macro View The next three to six months will provide sufficient evidence to resolve the war between The BULLS and BEARS that has...
News
The real estate and construction market has boomed in the past three years. The near-zero interest rates led to a demand influx for residential...
News
Dear readers/subscribers, If you’re new to Marsh & McLennan (NYSE:MMC) as an investment potential, then this might be the right article for you. I’ve...
News
Introduction and investment thesis Dynatrace (NYSE:DT) continued to impress investors in its FY2023 Q4 quarter, cementing its leading position besides Datadog (DDOG) as a...
News
Avid Bioservices (NASDAQ:CDMO), is a biologics contract development and manufacturing organization that offers full lifecycle capabilities from concept to commercial supply. The company has...
